Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer.
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection.Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 9, 2007 | Series B | $35M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Centrosome Ventures | — | Series B |
Georgia Venture Partners | — | Series B |